March 2020: EMA and ENCePP Encourage to Register COVID-19 Related Clinical Trials on EU PAS Register

As per the update on March 27, 2020, EMA and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) encouraged all researchers to register their pharmacoepidemiological studies related to the COVID-19 pandemic in the EU PAS Register. They should also upload and make their study protocols public, with a description of the data collected or planned to be collected. This is to facilitate collaborations and speed up the design of observational studies by others. Researchers should include ‘COVID-19’ in the study title to allow easy retrieval of all COVID-19-related studies via the ‘Title of Study’ search filter.

This recommendation does not further comment on the publication of the trials on EudraCT.

Leave a Reply